Promising statin alternative poised to bridge the gap

A new cholesterol-lowering medication that has fewer side-effects than statins has been hailed as a “breakthrough” by the Heart Foundation.

Evolocumab, branded Repatha, has been approved for use in Australia for patients with familial hypercholesterolaemia but has not yet made it onto the PBS.

The drug is administered as a pre-filled pen injection which must be given every few weeks. And it is likely to